121 related articles for article (PubMed ID: 21361708)
21. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.
Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L
Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942
[TBL] [Abstract][Full Text] [Related]
23. Photo induced hexylaminolevulinate destruction of rat bladder cells AY-27.
Ekroll IK; Gederaas OA; Helander L; Hjelde A; Melø TB; Johnsson A
Photochem Photobiol Sci; 2011 Jun; 10(6):1072-9. PubMed ID: 21424013
[TBL] [Abstract][Full Text] [Related]
24. Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ.
Bisson JF; Christophe M; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F
Anticancer Drugs; 2002 Sep; 13(8):851-7. PubMed ID: 12394271
[TBL] [Abstract][Full Text] [Related]
25. Red versus blue light illumination in hexyl 5-aminolevulinate photodynamic therapy: the influence of light color and irradiance on the treatment outcome in vitro.
Helander L; Krokan HE; Johnsson A; Gederaas OA; Plaetzer K
J Biomed Opt; 2014 Aug; 19(8):088002. PubMed ID: 25107536
[TBL] [Abstract][Full Text] [Related]
26. Changes in human skin after topical PDT with hexyl aminolevulinate.
Juzeniene A; Nielsen KP; Zhao L; Ryzhikov GA; Biryulina MS; Stamnes JJ; Stamnes K; Moan J
Photodiagnosis Photodyn Ther; 2008 Sep; 5(3):176-81. PubMed ID: 19356652
[TBL] [Abstract][Full Text] [Related]
27. Cancer immunoediting from immunosurveillance to tumor escape in microvillus-formed niche: a study of syngeneic orthotopic rat bladder cancer model in comparison with human bladder cancer.
Arum CJ; Anderssen E; Viset T; Kodama Y; Lundgren S; Chen D; Zhao CM
Neoplasia; 2010 Jun; 12(6):434-42. PubMed ID: 20563246
[TBL] [Abstract][Full Text] [Related]
28. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
Kamuhabwa AA; Roskams T; D'Hallewin MA; Baert L; Van Poppel H; de Witte PA
Int J Cancer; 2003 Nov; 107(3):460-7. PubMed ID: 14506748
[TBL] [Abstract][Full Text] [Related]
29. Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model.
Baglo Y; Peng Q; Hagen L; Berg K; Høgset A; Drabløs F; Gederaas OA
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):58-66. PubMed ID: 25575731
[TBL] [Abstract][Full Text] [Related]
30. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
31. Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid.
Baig M; Miocinovic R; Keck RW; Fynes EM; Strobel SL; Kropp KA; Selman SH
J Urol; 2007 Sep; 178(3 Pt 1):1108-12. PubMed ID: 17644132
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy of ovarian cancer peritoneal metastasis with hexaminolevulinate: a toxicity study.
Guyon L; Farine MO; Lesage JC; Gevaert AM; Simonin S; Schmitt C; Collinet P; Mordon S
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):265-74. PubMed ID: 24784431
[TBL] [Abstract][Full Text] [Related]
33. Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.
Shulok JR; Klaunig JE; Selman SH; Schafer PJ; Goldblatt PJ
Am J Pathol; 1986 Feb; 122(2):277-83. PubMed ID: 2936252
[TBL] [Abstract][Full Text] [Related]
34. Hexyl-aminolevulinate ethosome-mediated photodynamic therapy against acne: in vitro and in vivo analyses.
Wang T; Wu L; Wang Y; Song J; Zhang F; Zhu X
Drug Deliv Transl Res; 2022 Jan; 12(1):325-332. PubMed ID: 33730323
[TBL] [Abstract][Full Text] [Related]
35. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
Iinuma S; Bachor R; Flotte T; Hasan T
J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
[TBL] [Abstract][Full Text] [Related]
36. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells.
Gándara L; Sandes E; Di Venosa G; Prack Mc Cormick B; Rodriguez L; Mamone L; Batlle A; Eiján AM; Casas A
J Photochem Photobiol B; 2014 Apr; 133():55-64. PubMed ID: 24705371
[TBL] [Abstract][Full Text] [Related]
37. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
38. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
39. Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells.
Shahzidi S; Brech A; Sioud M; Li X; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2013 Oct; 339(1):25-32. PubMed ID: 23916608
[TBL] [Abstract][Full Text] [Related]
40. Porphyrin biodistribution in UV-exposed murine skin after methyl- and hexyl-aminolevulinate incubation.
Togsverd-Bo K; Lerche CM; Philipsen PA; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2012 Apr; 21(4):260-4. PubMed ID: 22320713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
